Creative Financial Designs Inc G1 Therapeutics, Inc. Transaction History

Creative Financial Designs Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 06, 2024	BUY	$2.2 - $4.98 $660 - $1,494	300 Added 0.74%	40,805 $93,000
Q1 2024 May 01, 2024	BUY	$2.1 - $4.83 $10,972 - $25,236	5,225 Added 14.81%	40,505 $174,000
Q4 2023 Jan 10, 2024	BUY	$1.12 - $3.73 $19,572 - $65,181	17,475 Added 98.15%	35,280 $107,000
Q3 2023 Nov 14, 2023	BUY	$1.22 - $2.67 $366 - $801	300 Added 1.71%	17,805 $25,000
Q2 2023 Jul 26, 2023	BUY	$2.46 - $3.14 $16,248 - $20,739	6,605 Added 60.6%	17,505 $43,000
Q1 2023 Apr 25, 2023	SELL	$2.57 - $8.16 $2,827 - $8,976	-1,100 Reduced 9.17%	10,900 $29,000
Q3 2022 Nov 01, 2022	BUY	$5.17 - $16.99 $62,040 - $203,879	12,000 New	12,000 $150,000

3.55M

11.7K

Ticker GTHX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,746,800
Market Cap $306M
Description
G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/...

Get notified when there are updates to the investment portfolio of Creative Financial Designs Inc , based on Form 13F filings with the SEC.

Stay updated on Creative Financial Designs Inc with notifications on news.